The TP53 gene, tobacco exposure, and lung cancer (Q35078733)

6 August 2017

1 reference

title

The TP53 gene, tobacco exposure, and lung cancer (English)

1 reference

6 August 2017

1 reference

Toshihide Tsuda

2

0 references

author name string

Shinichi Toyooka

series ordinal

1

1 reference

6 August 2017

Adi F Gazdar

series ordinal

3

1 reference

6 August 2017

publication date

1 March 2003

1 reference

6 August 2017

1 reference

6 August 2017

volume

21

1 reference

6 August 2017

issue

3

1 reference

6 August 2017

page(s)

229-239

1 reference

Molecular Detection of Tumor Cells in Bronchoalveolar Lavage Fluid From Patients With Early Stage Lung Cancer

6 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

The proline-rich domain of p53 is required for cooperation with anti-neoplastic agents to promote apoptosis of tumor cells

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

The UMD-p53 database: new mutations and analysis tools

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

TP53 and head and neck neoplasms

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

The pathogenesis of mesothelioma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

TP53 tumor suppressor gene: a model for investigating human mutagenesis

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Gender difference in DNA adduct levels among nonsmoking lung cancer patients

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Widely dispersed p53 mutation in respiratory epithelium. A novel mechanism for field carcinogenesis

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Distribution of p53 and K-ras mutations in human lung cancer tissues

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

p53 and angiogenesis in non-small-cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Gender comparisons in human lung cancer: analysis of p53 mutations, anti-p53 serum antibodies and C-erbB-2 expression

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

TP53 mutation spectrum in lung cancers and mutagenic signature of components of tobacco smoke: lessons from the IARC TP53 mutation database

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Patterns of p53 G-->T transversions in lung cancers reflect the primary mutagenic signature of DNA-damage by tobacco smoke

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

The Hallmarks of Cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

p53 tumor suppressor gene: from the basic research laboratory to the clinic--an abridged historical perspective

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Cigarette smoking and lung cancer: chemical mechanisms and approaches to prevention.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Immunohistochemical p53 protein status in nonsmall cell lung cancer is a promising indicator in determining in vitro chemosensitivity to some anticancer drugs

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

p53 gene mutation analysis in tumors of patients exposed to alpha-particles

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Radon and lung carcinogenesis: mutability of p53 codons 249 and 250 to 238Pu alpha-particles in human bronchial epithelial cells

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Tumor suppressor genes: at the crossroads of molecular carcinogenesis, molecular epidemiology and human risk assessment.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Identification of carcinoembryonic antigen-producing cells circulating in the blood of patients with colorectal carcinoma by reverse transcriptase polymerase chain reaction

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Atypical alveolar hyperplasia: relationship with pulmonary adenocarcinoma, p53, and c-erbB-2 expression

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Atypical adenomatous hyperplasia of the lung. Implications for the pathogenesis of peripheral lung adenocarcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Prognostic significance of p53 and bcl-2 abnormalities in operable nonsmall cell lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Molecular abnormalities in lung carcinogenesis and their potential clinical implications

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Mutations of p53 gene and SV40 sequences in asbestos associated and non-asbestos-associated mesotheliomas

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Detection and sequencing of p53 gene mutations in bronchial biopsy samples in patients with lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Absence of p53 mutations in malignant mesotheliomas

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Expression of vascular endothelial growth factor (VEGF) in non-small cell lung cancer (NSCLC): association with p53 gene mutation and prognosis.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

The IARC TP53 database: new online mutation analysis and recommendations to users

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Genetic changes in the spectrum of neuroendocrine lung tumors

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Cancer burden in the year 2000. The global picture

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Analysis of different versions of the IARC p53 database with respect to G-->T transversion mutation frequencies and mutation hotspots in lung cancer of smokers and non-smokers

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

'Smoke like a man, die like a man'?: a review of the relationship between gender, sex and lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Smoking, smoking cessation, and lung cancer in the UK since 1950: combination of national statistics with two case-control studies

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Successful treatment of primary and disseminated human lung cancers by systemic delivery of tumor suppressor genes using an improved liposome vector

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Human lung cancer and p53: the interplay between mutagenesis and selection

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Retrovirus-mediated wild-type p53 gene transfer to tumors of patients with lung cancer

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Adenovirus-mediated wild-type p53 gene transfer in patients receiving chemotherapy for advanced non-small-cell lung cancer: results of a multicenter phase II study

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Presence of simian virus 40 sequences in malignant pleural, peritoneal and noninvasive mesotheliomas

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

p53 alterations in atypical alveolar hyperplasia of the human lung

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Targeting of lung cancer mutational hotspots by polycyclic aromatic hydrocarbons

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Assessing TP53 status in human tumours to evaluate clinical outcome

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

p53: a frequent target for genetic abnormalities in lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

https://api.crossref.org/works/10.1002%2FHUMU.10177

1 reference

7 January 2021

TP53 mutations in workers exposed to occupational carcinogens

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

p53 Gene status in relation to ex vivo chemosensitivity of non-small cell lung cancer.

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Molecular Damage in the Bronchial Epithelium of Current and Former Smokers

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Sequential molecular abnormalities are involved in the multistage development of squamous cell lung carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Analysis of radon-associated squamous cell carcinomas of the lung for a p53 gene hotspot mutation

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Differences in lung cancer risk between men and women: examination of the evidence

1 reference

https://api.crossref.org/works/10.1002%2FHUMU.10177

7 January 2021

Identifiers

DOI

10.1002/HUMU.10177

1 reference

6 August 2017

1 reference